Quantcast

Latest Clinical trial Stories

2014-09-16 23:12:55

The research team at Avail Clinical is conducting a clinical study to evaluate a new remedy for the common cold. Adults who are experiencing early cold symptoms, but are otherwise healthy, may qualify to participate. DeLand, Florida (PRWEB) September 16, 2014 *Anyone who is interested in learning more about the clinical trials being conducted in DeLand, FL can visit Avail Clinical Research on the web (http://www.availclinical.com/trial/common-cold/) or contact them directly at (386)...

2014-09-16 23:11:40

Achieve Clinical Research is looking for adults who have never have not been vaccinated for pneumonia within the last year to take part in this new clinical study. Applicants should be at least 18 years old in order to qualify for a clinical trial here in Birmingham. Birmingham, Alabama (PRWEB) September 16, 2014 *To find out more about this pneumonia vaccine clinical trial in Birmingham, AL, visit Achieve Clinical Research on the web...

2014-09-16 23:04:40

For the first time, Orange Paper readers will have a detailed snapshot of clinical trials in Ukraine MOSCOW, Russia (PRWEB) September 16, 2014 Synergy Research Group has debuted the Ukraine Orange Paper. The comprehensive report gives the best detail and analysis of the state of clinical trials in Ukraine. Data was pulled from a variety of sources, including Ministry of Health in Ukraine and the FDA, etc. The Ukraine Orange Paper will give readers actionable intelligence on clinical...

2014-09-16 12:31:31

SAN DIEGO, Sept. 16, 2014 /PRNewswire/ -- Denovo Biopharma, LLC, today announced that it has acquired enzastaurin, a late-stage oncology drug, from Eli Lilly and Company (NYSE: LLY). Denovo gains all rights to develop, manufacture and commercialize enzastaurin globally, including transfer of all intellectual property and other rights, data, and information. http://photos.prnewswire.com/prnvar/20140820/138306 Lilly developed enzastaurin in a variety of indications, including in...

2014-09-16 12:30:26

BOSTON, September 16, 2014 /PRNewswire/ -- Russia's pharmaceutical market has been growing faster over recent years. The Pharma 2020 Strategy provides incentives for local producers to develop original and generic drugs for both domestic and foreign markets. These trends, however, were affected by recent developments connected with the political situation and the following political and economic sanctions imposed on Russia. (Logo:...

2014-09-16 08:30:30

"PIM" Designation For DCVax-L Is First Step In 2-Step Process for Early Access Approval BETHESDA, Md., Sept. 16, 2014 /PRNewswire/ -- Northwest Biotherapeutics (NASDAQ: NWBO) ("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, announced today that its DCVax-L is the first product to receive formal designation as a "Promising Innovative Medicine" (PIM) under the new "Early Access to Medicines Scheme" (EAMS) launched in the UK...

2014-09-15 12:24:42

TUCSON, Ariz., Sept. 15, 2014 /PRNewswire-USNewswire/ -- "Best practices" in medicine are based on clinical trials, which are supposedly at the highest level of evidence. But instead of bringing sound science into drug testing, clinical trials have brought a neglect of patients' individual needs and an epidemic of over-prescribing, writes Henry Bauer, Ph.D., in the fall issue of the Journal of American Physicians and Surgeons. The benefits of vaccination or antibiotics are readily...

2014-09-15 08:29:58

PLYMOUTH MEETING, Pa., Sept. 15, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) announced today that it has met the stringent listing criteria for the NASDAQ Global Select Market and effective today has transferred to this U.S. stock exchange from the NYSE MKT. The company will continue to trade under its current ticker symbol, "INO." NASDAQ Global Select Market, a segment of the NASDAQ Global Market, maintains the highest initial listing standards of any exchange...

2014-09-15 08:29:32

- Significantly Improved Agitation in 220-Patient 10-week Study - ALISO VIEJO, Calif., Sept. 15, 2014 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced positive results from its phase II clinical trial evaluating the safety and efficacy of AVP-923 for the treatment of agitation in patients with Alzheimer's disease. Treatment with AVP-923 was associated with significantly reduced agitation as measured by the primary endpoint, the agitation/aggression...

2014-09-15 08:29:28

Company CEO to present on September 17, 2014 JERUSALEM, September 15, 2014 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (http://www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today the Company's CEO, Nadav Kidron will present at DC Finance's Family Office & Wealth Management Annual Conference. Presentation Details: DC Finance's East Coast Family Office & Wealth...


Word of the Day
bellycheer
  • Good cheer; viands.
  • To revel; to feast.
The word 'bellycheer' may come from 'belle cheer', "good cheer".
Related